{"transactions":[{"id":723081,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T22:17:35.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 10, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.95,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-26-027007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126027007/form4.xml","form_type":"4"}},{"id":1120085,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:22:42.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":26000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001140361-25-021792","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125021792/form4.xml","form_type":"4"}},{"id":1431655,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-17T01:07:51.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through August 14, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":52000,"derivative":{"exercise_price":9.98,"expiration_date":"2034-08-14","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001140361-24-037713","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124037713/form4.xml","form_type":"4"}},{"id":1438024,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-08T20:31:51.000Z","date":"2024-08-06","kind":"grant","planned":false,"acquired":true,"shares":1866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest as to one-third on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":1866,"derivative":{"exercise_price":10.79,"expiration_date":"2034-08-06","underlying":"Common Stock","underlying_shares":1866},"source":{"system":"sec-edgar","filing":"0001140361-24-036417","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124036417/form4.xml","form_type":"4"}},{"id":1842723,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-06-28T20:02:20.000Z","date":"2023-06-27","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":6.7,"value":167500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of December 29, 2022."}],"balance_after":671423,"source":{"system":"sec-edgar","filing":"0001415889-23-010388","document":"form4-06282023_080616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588923010388/form4-06282023_080616.xml","form_type":"4"}},{"id":2013645,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T21:10:56.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":420000,"derivative":{"exercise_price":2.92,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001104659-23-022387","document":"tm236831-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000110465923022387/tm236831-3_4seq1.xml","form_type":"4"}},{"id":2388626,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T21:19:04.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":3.79,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-22-001517","document":"form4-02172022_010237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588922001517/form4-02172022_010237.xml","form_type":"4"}},{"id":2846339,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T23:46:47.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 17, 2022, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":225000,"derivative":{"exercise_price":28.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-007431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321007431/doc4.xml","form_type":"4"}},{"id":2915923,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T23:21:50.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":230116,"derivative":{"exercise_price":6.42,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-21-000741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321000741/doc4.xml","form_type":"4"}},{"id":2915922,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-06T23:21:50.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2015,"price":31.7989,"value":64074.7835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.55 to $32.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":696423,"source":{"system":"sec-edgar","filing":"0000899243-21-000741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321000741/doc4.xml","form_type":"4"}},{"id":2915921,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-06T23:21:50.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":9985,"price":30.9895,"value":309430.1575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.55 to $31.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":698438,"source":{"system":"sec-edgar","filing":"0000899243-21-000741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321000741/doc4.xml","form_type":"4"}},{"id":2915920,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-01-06T23:21:50.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":3000,"price":6.42,"value":19260.0,"ownership":{"direct":true},"balance_after":708423,"source":{"system":"sec-edgar","filing":"0000899243-21-000741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924321000741/doc4.xml","form_type":"4"}},{"id":2942734,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T00:39:56.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":233116,"derivative":{"exercise_price":6.42,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-20-034186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320034186/doc4.xml","form_type":"4"}},{"id":2942733,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-17T00:39:56.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":2500,"price":6.42,"value":16050.0,"ownership":{"direct":true},"balance_after":705423,"source":{"system":"sec-edgar","filing":"0000899243-20-034186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320034186/doc4.xml","form_type":"4"}},{"id":2958669,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-03T21:17:56.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":235616,"derivative":{"exercise_price":6.42,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-032670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320032670/doc4.xml","form_type":"4"}},{"id":2958668,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-03T21:17:56.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":1077,"price":33.4455,"value":36020.8035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $33.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":702923,"source":{"system":"sec-edgar","filing":"0000899243-20-032670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320032670/doc4.xml","form_type":"4"}},{"id":2958667,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-03T21:17:56.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":10923,"price":32.6424,"value":356552.9352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.19 to $33.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":704000,"source":{"system":"sec-edgar","filing":"0000899243-20-032670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320032670/doc4.xml","form_type":"4"}},{"id":2958666,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-03T21:17:56.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":3000,"price":6.42,"value":19260.0,"ownership":{"direct":true},"balance_after":714923,"source":{"system":"sec-edgar","filing":"0000899243-20-032670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320032670/doc4.xml","form_type":"4"}},{"id":2994886,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-04T00:56:14.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":238616,"derivative":{"exercise_price":6.42,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-030313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320030313/doc4.xml","form_type":"4"}},{"id":2994885,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-11-04T00:56:14.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":83,"price":31.875,"value":2645.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."}],"balance_after":711923,"source":{"system":"sec-edgar","filing":"0000899243-20-030313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320030313/doc4.xml","form_type":"4"}},{"id":2994884,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-11-04T00:56:14.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":11917,"price":31.1329,"value":371010.7693,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.74 to $31.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":712006,"source":{"system":"sec-edgar","filing":"0000899243-20-030313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320030313/doc4.xml","form_type":"4"}},{"id":2994883,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-11-04T00:56:14.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":3000,"price":6.42,"value":19260.0,"ownership":{"direct":true},"balance_after":723923,"source":{"system":"sec-edgar","filing":"0000899243-20-030313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320030313/doc4.xml","form_type":"4"}},{"id":3016406,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T21:07:24.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":241616,"derivative":{"exercise_price":6.42,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-026891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320026891/doc4.xml","form_type":"4"}},{"id":3016405,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-02T21:07:24.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":12000,"price":30.3302,"value":363962.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":720923,"source":{"system":"sec-edgar","filing":"0000899243-20-026891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320026891/doc4.xml","form_type":"4"}},{"id":3016404,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-02T21:07:24.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":3000,"price":6.42,"value":19260.0,"ownership":{"direct":true},"balance_after":732923,"source":{"system":"sec-edgar","filing":"0000899243-20-026891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320026891/doc4.xml","form_type":"4"}},{"id":3288855,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Preferred Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":13136,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4354},"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3288854,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":69636,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by wife."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23090},"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3288853,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Preferred Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":732560,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":242904},"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3288852,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":4354,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series B Preferred Stock had no expiration date."}],"balance_after":729923,"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3288851,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":23090,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by wife."}],"balance_after":23090,"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3288850,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-02-05T22:57:10.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":242904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-3.01581 basis. The Series A Preferred Stock had no expiration date."}],"balance_after":725569,"source":{"system":"sec-edgar","filing":"0000899243-20-003358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320003358/doc4.xml","form_type":"4"}},{"id":3296750,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34558,"kind":"person","name":"Epstein David M.","position":1,"cik":"0001488668","reported_name":"Epstein David M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-31T21:51:56.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":278532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":278532,"derivative":{"exercise_price":19,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":278532},"source":{"system":"sec-edgar","filing":"0000899243-20-002442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000089924320002442/doc4.xml","form_type":"4"}}]}